Evonik launches EUDRAGIT® E PO ReadyMix
The Evonik Pharma Polymers product line launches a new product: EUDRAGIT® E PO ReadyMix.
EUDRAGIT® E PO ReadyMix is a ready-to-use dry powder blend for taste masking and moisture protection coatings for oral solid dosage forms, based on the well-known, high performance EUDRAGIT® E PO polymer.
Main advantages are convenience of application, superior product performance and cost effectiveness in pharmaceutical production.
Essen, Germany-based Evonik Industries launches EUDRAGIT® E PO ReadyMix, a ready-to-use powder blend for taste masking and moisture protection coatings of pharma¬ceutical oral solid dosage forms. The new product is convenient to use and affords production cost savings, as well as superior performance for protective coatings.
"Until now, our customers had to source EUDRAGIT® E PO and all coating excipients and pigments separately from different suppliers. The exact weighing and mixing of the different raw materials were additional time-consuming production steps," explains Dr Thomas Riermeier, Head of the Evonik Pharma Polymers product line. "With the new product, burdensome preparation is a thing of the past. Preparation times now should be less than an hour. Additionally, we are able to match the customer’s exact color requirements," Riermeier adds.
Evonik developed and produces EUDRAGIT® E PO ReadyMix in close cooperation with BIOGRUND GmbH, a company based in Hünstetten, Germany. Evonik’s expertise in the area of functional polymers is complemented by BIOGRUND’s expertise in manufacturing and designing colored powder blends for pharmaceutical coatings.
Interested customers should contact Evonik sales representatives. Samples can be ordered immediately and will be available by the first quarter of 2012.
Pharma Polymers, a product line of the Health Care business line of Evonik, is a leader in drug delivery systems for oral and parenteral pharmaceutical dosage forms. Its EUDRAGIT® polymer products, used in film coatings and as matrix formers in oral drugs, are industry standards for enteric and sustained release drug formulations, as well as for solubility enhancement and protective coatings for taste masking and moisture protection. Evonik intends to enable formulators to design their drug products and their functionalities with the highest possible flexibility. The new product EUDRAGIT® E PO ReadyMix is no exception – it provides high flexibility while providing the advantages of a ready-to-use solid blend.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health and nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2010 more than 34,000 employees generated sales of around €13.3 billion and an operating profit (EBITDA) of about €2.4 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.